Krystal Biotech, Inc. (KRYS)

281.09 +8.96 (+3.29%) USD  |  NASDAQ  |  Jan 13, 13:06
More

Krystal Biotech Other Current Liability (Quarterly)

Other Current Liability (Quarterly) Chart

View Other Current Liability (Quarterly) for KRYS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Current Liability (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Current Liability (Quarterly) Range, Past 5 Years

View Other Current Liability (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Current Liability (Quarterly) Benchmarks

View Other Current Liability (Quarterly) Benchmarks
Start Trial
DexCom, Inc. --
BioLife Solutions, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. --